Features of the course of new coronaviral infection (COVID-19) in patients with acute kidney injury and end stage renal failure

BACKGROUND. In the modern era, COVID-19 is the biggest problem facing doctors and scientists around the world. SARSCоV-2 is a multisystem infection that is not limited to lung damage and has the immuno-mediated effect of negative effects on organs and systems, including the kidneys. To date, there is no precise understanding of the pathogenesis of nephrological disorders in patients with COVID-19. Patients with chronic kidney disease (CKD) are a group of particularly high risk of CO-VID-19 infection and high mortality in the development of the disease.

THE AIM: to evaluate the features of the course of a new coronavirus infection (COVID 19) in patients with acute kidney injury and terminal renal insufficiency.

PATIENTS AND METHODS. The study of clinical, laboratory and instrumental parameters was carried out in 119 patients (67 men and 52 women) diagnosed with COVID-19. The average age of the patients was 63.1±1.7 years. All patients were divided into two groups: group 1 - patients with CKD and HD, group 2 - patients with newly diagnosed kidney damage against the background of coronavirus infection (COVID-19). Statistical data analysis was carried out using the software package "IBM SPSS Statistics 21.0" (USA) (Russified version).

RESULTS. As a result of the study, it was found that in the clinical picture of COVID-19 patients suffering from CKD and undergoing hemodialysis, such a symptom as myalgia was noted 2 times more often, the percentage of saturation of arterial blood hemoglobin with oxygen (SaO₂,%) was significantly lower compared to patients with newly diagnosed kidney damage on the background of infection. The duration of the temperature reaction during the disease was 5 times longer than in patients without CKD. Although the incidence of lung damage in patients of both groups was identical, mortality was significantly higher in the group of patients with CKD.

CONCLUSION. In the patients examined by us, proteinuria, an increase in the level of nitrogenous metabolites, as well as D-dimers in both groups, are associated with increased mortality. Mortality in patients with CKD and HD was several times higher than in those without pathology of the urinary system. The severity of the patients' condition was primarily due to the symptoms of damage to the respiratory system, but the degree of renal dysfunction is undoubtedly an important prognostic value. Thus, monitoring the state of individual nephron structures in patients with CO-VID-19 is of great importance, and emergency nephroprotective measures may be crucial in the fight against cytokine storm.

1. Zumla A, Niederman MS. The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security. Curr Opin Pulm Med 2020;26(3):193-196. doi: 10.1097/MCP0000000000000676

2. Litvinov AS, Savin AV, Kukhtina AA, Sitovskaya DA. Clinical and morphological parallels of lung and kidney damage in COVID-19. Nephrology 2020;24(5):97-107

3. Zhen L, Ming W, Jiwei Ya, Jie G, Xiang L, Siji S et al. Caution on Kidney Dysfunctions of COVID-19 Patients (3/19/2020). MedRxiv 2020 doi: https://doi.org/10.1101/2020.02.08.20021212

4. Lin L, Lu L, Cao W, Li T Hypothesis for potential pathogenesis of SARS-CoV-2 infection - a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect 2020;9(1):727-732. doi: 10.1080/22221751.2020.1746199

5. Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med 2020;14(2):185-192. doi: 10.1007/s11684-020-0754-0

6. Yang XH, Sun RH, Chen DC. [Diagnosis and treatment of COVID-19: acute kidney injury cannot be ignored] [Article in Chinese]. Zhonghua Yi Xue Za Zhi 2020;100(16):1205-1208. doi: 10.3760/cma.j.cn112137-20200229-00520

7. Murkamilov IT, Aitbayev KA, Fomin V et al. Kidney function and cytokine profile changes in COVID-19. Clinical nephrology 2020;3:22-30

8. Becker RC. COVID-19-associated vasculitis and vas-culopathy. J Thromb Thrombolysis 2020 Oct;50(3):499-511. doi: 10.1007/s11239-020-02230-4

9. Gralinski LE, Bankhead A 3rd, Jeng S et al. Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury. mBio 2013;4(4):e00271-13

10. Sivkov AV, Koryakin AV, Sinyagin A et al. Genitourinary system and COVID-19: some aspects. Experimental and clinical urology 2020;2:18-23

11. Glybochko PV, Fomin VV, Avdeev SN et al. Clinical characteristics of 1007 patients with severe SARS-CoV-2 pneumonia who needed respiratory support. Klin pharmacolter 2020;29(2):21-29